0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Budesonide Capsules Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-31N6834
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Budesonide Capsules Market Insights Forecast to 2028
BUY CHAPTERS

Global Budesonide Capsules Market Research Report 2025

Code: QYRE-Auto-31N6834
Report
August 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Budesonide Capsules Market Size

The global market for Budesonide Capsules was valued at US$ 1056 million in the year 2024 and is projected to reach a revised size of US$ 1927 million by 2031, growing at a CAGR of 9.1% during the forecast period.

Budesonide Capsules Market

Budesonide Capsules Market

Budesonide is a first-line anti-inflammatory agent and locally acting glucocorticosteroid indicated for the induction and maintenance of remission of mild to moderate ileocaecal Crohn"s disease (capsules) and ulcerative colitis (enemas) as well as for the remission of active microscopic colitis (capsules).
North American market for Budesonide Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Budesonide Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Budesonide Capsules include Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, Amneal, Mayne Pharma, Sciecure Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Budesonide Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Budesonide Capsules.
The Budesonide Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Budesonide Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Budesonide Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Budesonide Capsules Market Report

Report Metric Details
Report Name Budesonide Capsules Market
Accounted market size in year US$ 1056 million
Forecasted market size in 2031 US$ 1927 million
CAGR 9.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 1mg
  • 2mg
  • 3mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, Amneal, Mayne Pharma, Sciecure Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Budesonide Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Budesonide Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Budesonide Capsules Market growing?

Ans: The Budesonide Capsules Market witnessing a CAGR of 9.1% during the forecast period 2025-2031.

What is the Budesonide Capsules Market size in 2031?

Ans: The Budesonide Capsules Market size in 2031 will be US$ 1927 million.

Who are the main players in the Budesonide Capsules Market report?

Ans: The main players in the Budesonide Capsules Market are Perrigo, Mylan, Tillotts Pharma, Teva, Zydus Pharmaceuticals, Amneal, Mayne Pharma, Sciecure Pharma

What are the Application segmentation covered in the Budesonide Capsules Market report?

Ans: The Applications covered in the Budesonide Capsules Market report are Crohn's Disease, Collagenous Colitis, Autoimmune Hepatitis

What are the Type segmentation covered in the Budesonide Capsules Market report?

Ans: The Types covered in the Budesonide Capsules Market report are 1mg, 2mg, 3mg

Recommended Reports

Capsule Pharmaceuticals

Inflammatory Bowel Diseases

Budesonide Products

1 Budesonide Capsules Market Overview
1.1 Product Definition
1.2 Budesonide Capsules by Type
1.2.1 Global Budesonide Capsules Market Value Comparison by Type (2024 VS 2031)
1.2.2 1mg
1.2.3 2mg
1.2.4 3mg
1.3 Budesonide Capsules by Application
1.3.1 Global Budesonide Capsules Market Value by Application (2024 VS 2031)
1.3.2 Crohn's Disease
1.3.3 Collagenous Colitis
1.3.4 Autoimmune Hepatitis
1.4 Global Budesonide Capsules Market Size Estimates and Forecasts
1.4.1 Global Budesonide Capsules Revenue 2020-2031
1.4.2 Global Budesonide Capsules Sales 2020-2031
1.4.3 Global Budesonide Capsules Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Budesonide Capsules Market Competition by Manufacturers
2.1 Global Budesonide Capsules Sales Market Share by Manufacturers (2020-2025)
2.2 Global Budesonide Capsules Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Budesonide Capsules Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Budesonide Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Budesonide Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Budesonide Capsules, Product Type & Application
2.7 Global Key Manufacturers of Budesonide Capsules, Date of Enter into This Industry
2.8 Global Budesonide Capsules Market Competitive Situation and Trends
2.8.1 Global Budesonide Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Budesonide Capsules Players Market Share by Revenue
2.8.3 Global Budesonide Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Budesonide Capsules Market Scenario by Region
3.1 Global Budesonide Capsules Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Budesonide Capsules Sales by Region: 2020-2031
3.2.1 Global Budesonide Capsules Sales by Region: 2020-2025
3.2.2 Global Budesonide Capsules Sales by Region: 2026-2031
3.3 Global Budesonide Capsules Revenue by Region: 2020-2031
3.3.1 Global Budesonide Capsules Revenue by Region: 2020-2025
3.3.2 Global Budesonide Capsules Revenue by Region: 2026-2031
3.4 North America Budesonide Capsules Market Facts & Figures by Country
3.4.1 North America Budesonide Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Budesonide Capsules Sales by Country (2020-2031)
3.4.3 North America Budesonide Capsules Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Budesonide Capsules Market Facts & Figures by Country
3.5.1 Europe Budesonide Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Budesonide Capsules Sales by Country (2020-2031)
3.5.3 Europe Budesonide Capsules Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Budesonide Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Budesonide Capsules Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Budesonide Capsules Sales by Region (2020-2031)
3.6.3 Asia Pacific Budesonide Capsules Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Budesonide Capsules Market Facts & Figures by Country
3.7.1 Latin America Budesonide Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Budesonide Capsules Sales by Country (2020-2031)
3.7.3 Latin America Budesonide Capsules Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Budesonide Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Budesonide Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Budesonide Capsules Sales by Country (2020-2031)
3.8.3 Middle East and Africa Budesonide Capsules Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Budesonide Capsules Sales by Type (2020-2031)
4.1.1 Global Budesonide Capsules Sales by Type (2020-2025)
4.1.2 Global Budesonide Capsules Sales by Type (2026-2031)
4.1.3 Global Budesonide Capsules Sales Market Share by Type (2020-2031)
4.2 Global Budesonide Capsules Revenue by Type (2020-2031)
4.2.1 Global Budesonide Capsules Revenue by Type (2020-2025)
4.2.2 Global Budesonide Capsules Revenue by Type (2026-2031)
4.2.3 Global Budesonide Capsules Revenue Market Share by Type (2020-2031)
4.3 Global Budesonide Capsules Price by Type (2020-2031)
5 Segment by Application
5.1 Global Budesonide Capsules Sales by Application (2020-2031)
5.1.1 Global Budesonide Capsules Sales by Application (2020-2025)
5.1.2 Global Budesonide Capsules Sales by Application (2026-2031)
5.1.3 Global Budesonide Capsules Sales Market Share by Application (2020-2031)
5.2 Global Budesonide Capsules Revenue by Application (2020-2031)
5.2.1 Global Budesonide Capsules Revenue by Application (2020-2025)
5.2.2 Global Budesonide Capsules Revenue by Application (2026-2031)
5.2.3 Global Budesonide Capsules Revenue Market Share by Application (2020-2031)
5.3 Global Budesonide Capsules Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Perrigo
6.1.1 Perrigo Company Information
6.1.2 Perrigo Description and Business Overview
6.1.3 Perrigo Budesonide Capsules Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Perrigo Budesonide Capsules Product Portfolio
6.1.5 Perrigo Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Company Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Budesonide Capsules Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mylan Budesonide Capsules Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Tillotts Pharma
6.3.1 Tillotts Pharma Company Information
6.3.2 Tillotts Pharma Description and Business Overview
6.3.3 Tillotts Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Tillotts Pharma Budesonide Capsules Product Portfolio
6.3.5 Tillotts Pharma Recent Developments/Updates
6.4 Teva
6.4.1 Teva Company Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Budesonide Capsules Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Teva Budesonide Capsules Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Zydus Pharmaceuticals
6.5.1 Zydus Pharmaceuticals Company Information
6.5.2 Zydus Pharmaceuticals Description and Business Overview
6.5.3 Zydus Pharmaceuticals Budesonide Capsules Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Zydus Pharmaceuticals Budesonide Capsules Product Portfolio
6.5.5 Zydus Pharmaceuticals Recent Developments/Updates
6.6 Amneal
6.6.1 Amneal Company Information
6.6.2 Amneal Description and Business Overview
6.6.3 Amneal Budesonide Capsules Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Amneal Budesonide Capsules Product Portfolio
6.6.5 Amneal Recent Developments/Updates
6.7 Mayne Pharma
6.7.1 Mayne Pharma Company Information
6.7.2 Mayne Pharma Description and Business Overview
6.7.3 Mayne Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mayne Pharma Budesonide Capsules Product Portfolio
6.7.5 Mayne Pharma Recent Developments/Updates
6.8 Sciecure Pharma
6.8.1 Sciecure Pharma Company Information
6.8.2 Sciecure Pharma Description and Business Overview
6.8.3 Sciecure Pharma Budesonide Capsules Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sciecure Pharma Budesonide Capsules Product Portfolio
6.8.5 Sciecure Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Budesonide Capsules Industry Chain Analysis
7.2 Budesonide Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Budesonide Capsules Production Mode & Process Analysis
7.4 Budesonide Capsules Sales and Marketing
7.4.1 Budesonide Capsules Sales Channels
7.4.2 Budesonide Capsules Distributors
7.5 Budesonide Capsules Customer Analysis
8 Budesonide Capsules Market Dynamics
8.1 Budesonide Capsules Industry Trends
8.2 Budesonide Capsules Market Drivers
8.3 Budesonide Capsules Market Challenges
8.4 Budesonide Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Budesonide Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Budesonide Capsules Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Budesonide Capsules Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Budesonide Capsules Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Budesonide Capsules Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Budesonide Capsules Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Budesonide Capsules Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Budesonide Capsules Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Budesonide Capsules, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Budesonide Capsules, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Budesonide Capsules, Product Type & Application
 Table 12. Global Key Manufacturers of Budesonide Capsules, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Budesonide Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Budesonide Capsules as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Budesonide Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Budesonide Capsules Sales by Region (2020-2025) & (K Units)
 Table 18. Global Budesonide Capsules Sales Market Share by Region (2020-2025)
 Table 19. Global Budesonide Capsules Sales by Region (2026-2031) & (K Units)
 Table 20. Global Budesonide Capsules Sales Market Share by Region (2026-2031)
 Table 21. Global Budesonide Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Budesonide Capsules Revenue Market Share by Region (2020-2025)
 Table 23. Global Budesonide Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Budesonide Capsules Revenue Market Share by Region (2026-2031)
 Table 25. North America Budesonide Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Budesonide Capsules Sales by Country (2020-2025) & (K Units)
 Table 27. North America Budesonide Capsules Sales by Country (2026-2031) & (K Units)
 Table 28. North America Budesonide Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Budesonide Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Budesonide Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Budesonide Capsules Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Budesonide Capsules Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Budesonide Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Budesonide Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Budesonide Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Budesonide Capsules Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Budesonide Capsules Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Budesonide Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Budesonide Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Budesonide Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Budesonide Capsules Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Budesonide Capsules Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Budesonide Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Budesonide Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Budesonide Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Budesonide Capsules Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Budesonide Capsules Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Budesonide Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Budesonide Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Budesonide Capsules Sales (K Units) by Type (2020-2025)
 Table 51. Global Budesonide Capsules Sales (K Units) by Type (2026-2031)
 Table 52. Global Budesonide Capsules Sales Market Share by Type (2020-2025)
 Table 53. Global Budesonide Capsules Sales Market Share by Type (2026-2031)
 Table 54. Global Budesonide Capsules Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Budesonide Capsules Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Budesonide Capsules Revenue Market Share by Type (2020-2025)
 Table 57. Global Budesonide Capsules Revenue Market Share by Type (2026-2031)
 Table 58. Global Budesonide Capsules Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Budesonide Capsules Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Budesonide Capsules Sales (K Units) by Application (2020-2025)
 Table 61. Global Budesonide Capsules Sales (K Units) by Application (2026-2031)
 Table 62. Global Budesonide Capsules Sales Market Share by Application (2020-2025)
 Table 63. Global Budesonide Capsules Sales Market Share by Application (2026-2031)
 Table 64. Global Budesonide Capsules Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Budesonide Capsules Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Budesonide Capsules Revenue Market Share by Application (2020-2025)
 Table 67. Global Budesonide Capsules Revenue Market Share by Application (2026-2031)
 Table 68. Global Budesonide Capsules Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Budesonide Capsules Price (USD/Unit) by Application (2026-2031)
 Table 70. Perrigo Company Information
 Table 71. Perrigo Description and Business Overview
 Table 72. Perrigo Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Perrigo Budesonide Capsules Product
 Table 74. Perrigo Recent Developments/Updates
 Table 75. Mylan Company Information
 Table 76. Mylan Description and Business Overview
 Table 77. Mylan Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Mylan Budesonide Capsules Product
 Table 79. Mylan Recent Developments/Updates
 Table 80. Tillotts Pharma Company Information
 Table 81. Tillotts Pharma Description and Business Overview
 Table 82. Tillotts Pharma Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Tillotts Pharma Budesonide Capsules Product
 Table 84. Tillotts Pharma Recent Developments/Updates
 Table 85. Teva Company Information
 Table 86. Teva Description and Business Overview
 Table 87. Teva Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Teva Budesonide Capsules Product
 Table 89. Teva Recent Developments/Updates
 Table 90. Zydus Pharmaceuticals Company Information
 Table 91. Zydus Pharmaceuticals Description and Business Overview
 Table 92. Zydus Pharmaceuticals Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Zydus Pharmaceuticals Budesonide Capsules Product
 Table 94. Zydus Pharmaceuticals Recent Developments/Updates
 Table 95. Amneal Company Information
 Table 96. Amneal Description and Business Overview
 Table 97. Amneal Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Amneal Budesonide Capsules Product
 Table 99. Amneal Recent Developments/Updates
 Table 100. Mayne Pharma Company Information
 Table 101. Mayne Pharma Description and Business Overview
 Table 102. Mayne Pharma Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Mayne Pharma Budesonide Capsules Product
 Table 104. Mayne Pharma Recent Developments/Updates
 Table 105. Sciecure Pharma Company Information
 Table 106. Sciecure Pharma Description and Business Overview
 Table 107. Sciecure Pharma Budesonide Capsules Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Sciecure Pharma Budesonide Capsules Product
 Table 109. Sciecure Pharma Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Budesonide Capsules Distributors List
 Table 113. Budesonide Capsules Customers List
 Table 114. Budesonide Capsules Market Trends
 Table 115. Budesonide Capsules Market Drivers
 Table 116. Budesonide Capsules Market Challenges
 Table 117. Budesonide Capsules Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Budesonide Capsules
 Figure 2. Global Budesonide Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Budesonide Capsules Market Share by Type: 2024 & 2031
 Figure 4. 1mg Product Picture
 Figure 5. 2mg Product Picture
 Figure 6. 3mg Product Picture
 Figure 7. Global Budesonide Capsules Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Budesonide Capsules Market Share by Application: 2024 & 2031
 Figure 9. Crohn's Disease
 Figure 10. Collagenous Colitis
 Figure 11. Autoimmune Hepatitis
 Figure 12. Global Budesonide Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Budesonide Capsules Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Budesonide Capsules Sales (2020-2031) & (K Units)
 Figure 15. Global Budesonide Capsules Average Price (USD/Unit) & (2020-2031)
 Figure 16. Budesonide Capsules Report Years Considered
 Figure 17. Budesonide Capsules Sales Share by Manufacturers in 2024
 Figure 18. Global Budesonide Capsules Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Budesonide Capsules Players: Market Share by Revenue in Budesonide Capsules in 2024
 Figure 20. Budesonide Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Budesonide Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Budesonide Capsules Sales Market Share by Country (2020-2031)
 Figure 23. North America Budesonide Capsules Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Budesonide Capsules Sales Market Share by Country (2020-2031)
 Figure 27. Europe Budesonide Capsules Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Budesonide Capsules Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Budesonide Capsules Revenue Market Share by Region (2020-2031)
 Figure 35. China Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Budesonide Capsules Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Budesonide Capsules Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Budesonide Capsules Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Budesonide Capsules Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Budesonide Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Budesonide Capsules by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Budesonide Capsules by Type (2020-2031)
 Figure 57. Global Budesonide Capsules Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Budesonide Capsules by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Budesonide Capsules by Application (2020-2031)
 Figure 60. Global Budesonide Capsules Price (USD/Unit) by Application (2020-2031)
 Figure 61. Budesonide Capsules Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D19461
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global OTC Hydrotalcite Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18S16538
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Women's Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14W1499
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Yohimbine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Y1251
Thu Sep 11 00:00:00 UTC 2025

Add to Cart